Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines

INTRODUCTION: Bisphosphonates are inhibitors of osteoclast-mediated tumor-stimulated osteolysis, and they have become standard therapy for the management of bone metastases from breast cancer. These drugs can also directly induce growth inhibition and apoptosis of osteotropic cancer cells, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Journe, Fabrice, Chaboteaux, Carole, Magne, Nicolas, Duvillier, Hugues, Laurent, Guy, Body, Jean-Jacques
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413981/
https://www.ncbi.nlm.nih.gov/pubmed/16417650
http://dx.doi.org/10.1186/bcr1363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413981/
https://www.ncbi.nlm.nih.gov/pubmed/16417650
http://dx.doi.org/10.1186/bcr1363

Ejemplares similares